
Neuroscience of Coffee Part B
- 1st Edition, Volume 289 - August 19, 2024
- Imprint: Academic Press
- Editors: Nasrollah Moradikor, Indranath Chatterjee
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 6 7 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 6 8 - 8
Neuroscience of Coffee, Volume 289 is a pioneering volume that delves into the intricate relationship between one of the world's most beloved beverages and the human brain. Offeri… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteAdditional chapters explore Coffee, Antioxidants, and Brain Inflammation, Behavioral and Psychological Aspects of Coffee Consumption, From Bean to Brain: Coffee, Gray Matter, and Neuroprotection in Neurological Disorders Spectrum, and Synaptic Modulation by Coffee Compounds: Insights into Neural Plasticity.
- Provides an in-Depth Exploration of Biochemical and Physiological Mechanisms
- Investigates the intricate biochemical and physiological processes that underscore the impact of coffee and its constituents, providing essential insights for professionals and students in neuroscience
- Covers Mental Health and Neurodegenerative Diseases
- Offers valuable resources for healthcare professionals and individuals affected by these neurological and neurodegenerative conditions
- Cover image
- Title page
- Table of Contents
- Series Page
- Copyright
- Contributors
- Preface
- Chapter One Coffee and Parkinson's disease
- Abstract
- 1 Introduction
- 2 Active constituents in coffee
- 3 Motor and non-motor benefit of coffee in PD
- 4 Interaction of coffee's constituents with α-syn aggregation
- 5 PD, gut microbiota and coffee
- 6 Conclusion
- References
- Chapter Two Coffee and Alzheimer's disease
- Abstract
- 1 Introduction
- 2 Pathophysiology of Alzheimer's disease: Exploring established hypotheses
- 3 Bioactive constituents of coffee: Exploring their physiological properties
- 4 Bioactive constituents of coffee: Exploring their pharmacological properties
- 5 Coffee's neuroprotective arsenal: Safeguarding against Alzheimer's
- 6 Addressing controversial findings and charting future directions
- 7 Conclusion
- References
- Chapter Three Coffee and multiple sclerosis (MS)
- Abstract
- 1 Introduction
- 2 Multiple sclerosis (MS)
- 3 The connection between coffee consumption and multiple sclerosis (MS)
- 4 Pathological hallmarks of MS
- 5 Role of microglial cells in MS
- 6 The multifaceted role of microglial cells
- 7 Modulation of adenosine receptors
- 8 Effects of caffeine on adenosine receptors
- 9 Role of A2AR in MS
- 10 Potential therapeutic approaches, risks and considerations
- 11 Conclusion
- References
- Chapter Four Coffee and amyotrophic lateral sclerosis (ALS)
- Abstract
- 1 Introduction
- 2 Amyotrophic lateral sclerosis (ALS) as a neurodegenerative disease
- 3 Epidemiology of ALS
- 4 ALS current treatment options and clinical challenges
- 5 Coffee history and cultural significance of coffee consumption
- 6 Coffee bioactive compounds
- 7 Potential health benefits of coffee consumption
- 8 Coffee consumption and ALS: Clinical and experimental evidence
- 9 Potential mechanisms of action of coffee in ALS neuropathology
- 10 Recommendations and future directions
- 11 Conclusion
- References
- Chapter Five Exploring the complex relationship between caffeine consumption and schizophrenia: A review of epidemiological and clinical studies
- Abstract
- 1 Introduction
- 2 Coffee consumption patterns
- 3 Mechanism of action
- 4 Epidemiological studies
- 5 Clinical studies
- 6 Potential mechanisms
- 7 Caffeine as a risk factor
- 8 Clinical implications
- 9 Limitations and future directions
- 10 Conclusion
- References
- Chapter Six Coffee, antioxidants, and brain inflammation
- Abstract
- 1 Introduction
- 2 Major chemical compounds of coffee
- 3 Brain inflammation
- 4 Coffee and brain inflammation
- 5 Anti-inflammatory activity of chlorogenic acids in coffee
- 6 Caffeine: A strong ally to weaken neuroinflammation
- 7 Neuroinflammation, neurodegeneration and caffeine
- 8 Neuroprotective effect of caffeine in neuroinflammatory and neurodegenerative diseases
- 9 Pyrocatechol: A coffee component inhibits neuroinflammation via inhibition of NF-κB in microglia
- 10 Conclusion
- Acknowledgments
- References
- Further reading
- Chapter Seven Behavioral and psychological aspects of coffee consumption
- Abstract
- 1 Introduction
- 2 Behavioral effects of coffee consumption
- 3 Psychological implications of coffee consumption
- 4 Social and cultural factors
- 5 Coffee consumption and behavior change interventions
- 6 Future directions
- 7 Conclusion
- References
- Chapter Eight From bean to brain: Coffee, gray matter, and neuroprotection in neurological disorders spectrum
- Abstract
- 1 Introduction
- 2 Coffee and the brain: Insights from literature
- 3 Coffee and schizophrenia: Current understanding and implications
- 4 Discussion and future opportunity
- References
- Chapter Nine Synaptic modulation by coffee compounds: Insights into neural plasticity
- Abstract
- 1 Introduction
- 2 Coffee compounds in neural plasticity
- 3 Coffee and the neural plasticity: The interplay?
- 4 Primary neuropharmacological effects of caffeine on different neurotransmitters
- 5 Modern neurobiological definition of neuroplasticity
- 6 Conclusion
- References
- Edition: 1
- Volume: 289
- Published: August 19, 2024
- Imprint: Academic Press
- No. of pages: 358
- Language: English
- Hardback ISBN: 9780443344671
- eBook ISBN: 9780443344688
NM
Nasrollah Moradikor
Dr. Nasrollah Moradikor is currently the research director and principal investigator at the International Center for Neuroscience Research in Tbilisi, Georgia. He has demonstrated exceptional leadership skills in promoting applied neuroscience research and establishing fruitful collaborations among scientists worldwide. Dr. Nasrallah's research program is dedicated to developing interventions for the prevention and treatment of neurological disorders. His team investigates the molecular mechanisms and therapeutics of brain disorders, including Parkinson's and Alzheimer's diseases, employing both clinical and experimental models. In 2021, Dr. Nasrollah founded a new community platform named “Neuroscience Network” to support and develop neuroscience in the world. His ability to create a supportive and intellectually stimulating environment has been instrumental in promoting the development of aspiring neuroscientists. He established robust international research collaborations with institutions in the USA, Australia, Canada, France, Germany, South Korea, and Malaysia. He has over 15 years of research and teaching experience in the field of brain health. Nasrollah has been on the scientific advisory board and evaluation committees of several institutions abroad. He currently serves as an editor, editorial board member and section editor of several reputed journals in the field of neuroscience. His contributions to the scientific community are evident through his publications, as well as more than 15 years of editorial expertise. He is an active professional member of IBRO, FENS, EBBS, ISN, ESN, ENCP, MNS, and MDS.
IC